logo

For the Inventor, By the Inventor

Garnerville, NY, United States of America

Philip R Hamann

USPTO Granted Patents = 19


Average Co-Inventor Count = 4.2

ph-index = 12

Forward Citations = 2,948(Granted Patents)


Location History:

  • New York, NY (US) (1987)
  • Pearl River, NY (US) (1988)
  • Gernerville, NY (US) (2001)
  • Garnerville, NY (US) (1991 - 2003)

Company Filing History:

goldMedal17 out of 3,580 
 
American Cyanamid Company
 patents
silverMedal2 out of 2,489 
 
Columbia University
 patents

Years Active: 1987-2003

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents
1. 6548496 - Substituted 3-cyano-[1.7], [1.5], and [1.8] naphthyridine inhibitors of tyrosine kinases (2003-04-15),
2. 6355636 - Substituted 3-cyano-[1.7],[1.5], and [1.8] naphthyridine inhibitors of tyrosine kinases (2002-03-12),
3. 6297258 - Substituted 3-cyanoquinolines (2001-10-02),
4. 6288082 - Substituted 3-cyanoquinolines (2001-09-11),
5. 6251912 - Substituted quinazoline derivatives (2001-06-26),
6. 6015562 - Targeted forms of methyltrithio antitumor agents (2000-01-18),
7. 5877296 - Process for preparing conjugates of methyltrithio antitumor agents (1999-03-02),
8. 5773001 - Conjugates of methyltrithio antitumor agents and intermediates for their (1998-06-30),
9. 5770701 - Process for preparing targeted forms of methyltrithio antitumor agents (1998-06-23),
10. 5767285 - Linkers useful for the synthesis of conjugates of methyltrithio (1998-06-16),
11. 5739116 - Enediyne derivatives useful for the synthesis of conjugates of (1998-04-14),
12. 5714586 - Methods for the preparation of monomeric calicheamicin (1998-02-03),
13. 5712374 - Method for the preparation of substantiallly monomeric calicheamicin (1998-01-27),
14. 5208223 - Phosphocholine derivative inhibitors of phospholipase A.sub.2 (1993-05-04),
15. 5144045 - Phosphocholine derivative inhibitors of phospholipase A.sub.2 (1992-09-01),

Certainly! Here's the article about the inventor Philip R Hamann based on the information provided:

Title: The Innovator: Philip R Hamann's Contributions to Science and Technology

Introduction:

Philip R Hamann, a dedicated inventor based in Garnerville, NY, has made significant strides in the field of science with a remarkable portfolio of 19 patents to his name. His innovative spirit and commitment to pushing boundaries have led to groundbreaking discoveries in various areas of technology.

Latest Patents:

Among his latest patents is the groundbreaking "Substituted 3-cyano-[1.7], [1.5], and [1.8] naphthyridine inhibitors of tyrosine kinases," showcasing his expertise in developing novel compounds that have the potential to revolutionize the pharmaceutical industry.

Career Highlights:

Philip R Hamann's illustrious career has seen him contribute his expertise to renowned companies such as the American Cyanamid Company and Columbia University in the City of New York. Through his work, he has demonstrated a keen understanding of scientific principles and a knack for translating ideas into tangible innovations.

Collaborations:

In his professional journey, Philip R Hamann has collaborated with esteemed individuals in the field, including Allan Wissner and Lois M Hinman. These partnerships have not only enriched his work but have also paved the way for multidisciplinary approaches to problem-solving and innovation.

Conclusion:

In conclusion, Philip R Hamann's inventive spirit, coupled with his extensive knowledge and experience, has solidified his position as a trailblazer in the world of technology and innovation. His contributions have not only advanced scientific knowledge but have also laid the foundation for future generations of inventors to build upon.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…